Cargando…
Systemic inflammation as a biomarker of seizure propensity and a target for treatment to reduce seizure propensity
People with diabetes can wear a device that measures blood glucose and delivers just the amount of insulin needed to return the glucose level to within bounds. Currently, people with epilepsy do not have access to an equivalent wearable device that measures a systemic indicator of an impending seizu...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978091/ https://www.ncbi.nlm.nih.gov/pubmed/36524286 http://dx.doi.org/10.1002/epi4.12684 |